A Brief History of IL-9

IL-9 was first described in the late 1980s as a member of a growing number of cytokines that had pleiotropic functions in the immune system. Although many biological functions have been attributed to IL-9, it remains an understudied cytokine. A resurgence of interest in IL-9 has been spurred by recent work demonstrating a role for IL-9 in regulating inflammatory immunity and defining the transcription factors that activate the Il9 gene in cells that most efficiently produce IL-9. In this review, we summarize the characterization of IL-9 biological activities, highlight roles for the cytokine that are clearly defined, and outline questions regarding IL-9 functions that still require further exploration.

[1]  Y. Brewah,et al.  IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. , 2011, American journal of respiratory and critical care medicine.

[2]  G. Mayer,et al.  IL-9 Production by Regulatory T Cells Recruits Mast Cells That Are Essential for Regulatory T Cell-Induced Immune Suppression , 2011, The Journal of Immunology.

[3]  E. Wawrousek,et al.  Antigen-Specific Th9 Cells Exhibit Uniqueness in Their Kinetics of Cytokine Production and Short Retention at the Inflammatory Site , 2010, The Journal of Immunology.

[4]  B. Nourbakhsh,et al.  Neutralization of IL-9 Ameliorates Experimental Autoimmune Encephalomyelitis by Decreasing the Effector T Cell Population , 2010, The Journal of Immunology.

[5]  H. Schild,et al.  Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. , 2010, Immunity.

[6]  Michael N. Alonso,et al.  Regulation of human Th9 differentiation by type I interferons and IL‐21 , 2010, Immunology and cell biology.

[7]  Samia J. Khoury,et al.  TGF-β Induces IL-9 Production from Human Th17 Cells , 2010, The Journal of Immunology.

[8]  T. Kimman,et al.  Interleukin‐9 polymorphism in infants with respiratory syncytial virus infection: An opposite effect in boys and girls , 2010, Pediatric pulmonology.

[9]  Qing Yu,et al.  The transcription factor PU.1 is required for the development of interleukin 9-producing T cells and allergic inflammation , 2010, Nature Immunology.

[10]  S. Muro,et al.  IL-9 Induces CCL11 Expression via STAT3 Signalling in Human Airway Smooth Muscle Cells , 2010, PloS one.

[11]  H. Watarai,et al.  Regulation of IL-9 expression by IL-25 signaling , 2010, Nature Immunology.

[12]  J. Renauld,et al.  Differential roles for the IL-9/IL-9 receptor alpha-chain pathway in systemic and oral antigen-induced anaphylaxis. , 2010, The Journal of allergy and clinical immunology.

[13]  A. Awasthi,et al.  Human CD4+ Memory T Cells Can Become CD4+IL-9+ T Cells , 2010, PloS one.

[14]  V. Kuchroo,et al.  Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes1 , 2009, The Journal of Immunology.

[15]  J. Van Snick,et al.  IL-9 Regulates Pathology during Primary and Memory Responses to Respiratory Syncytial Virus Infection1 , 2009, The Journal of Immunology.

[16]  M. Kaplan,et al.  PU.1 Regulates TCR Expression by Modulating GATA-3 Activity1 , 2009, The Journal of Immunology.

[17]  B. Prum,et al.  Association of the X-Chromosomal Genes TIMP1 and IL9R with Rheumatoid Arthritis , 2009, The Journal of Rheumatology.

[18]  B. Becher,et al.  IL-9 as a mediator of Th17-driven inflammatory disease , 2009, The Journal of experimental medicine.

[19]  M. Kaplan,et al.  IFN Regulatory Factor 4 Regulates the Expression of a Subset of Th2 Cytokines1 , 2009, The Journal of Immunology.

[20]  M. Lathrop,et al.  Sex-specific effect of IL9 polymorphisms on lung function and polysensitization , 2009, Genes and Immunity.

[21]  J. Renauld,et al.  IL-9 Promotes IL-13-Dependent Paneth Cell Hyperplasia and Up-Regulation of Innate Immunity Mediators in Intestinal Mucosa 1 , 2009, The Journal of Immunology.

[22]  W. White,et al.  Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers. , 2009, Clinical therapeutics.

[23]  J. Renauld,et al.  IL-9 Induces Differentiation of TH17 Cells and Enhances Function of FoxP3+Natural Regulatory T Cells , 2009 .

[24]  Christoph Wilhelm,et al.  Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.

[25]  F. Finkelman,et al.  IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity , 2008, The Journal of experimental medicine.

[26]  Q. Hamid,et al.  Expression of IL-9 receptor α chain on human germinal center B cells modulates IgE secretion , 2007 .

[27]  T. Mak,et al.  The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 , 2007, Nature Immunology.

[28]  M. Jordana,et al.  Immunoreactivity profile of peripheral blood mononuclear cells from patients with ragweed‐induced allergic rhinitis , 2007, Clinical and Experimental Allergy.

[29]  J. Renauld,et al.  IL-13 Mediates In Vivo IL-9 Activities on Lung Epithelial Cells but Not on Hematopoietic Cells1 , 2007, The Journal of Immunology.

[30]  H. Schild,et al.  p38 MAP kinase drives the expression of mast cell-derived IL-9 via activation of the transcription factor GATA-1. , 2007, Molecular immunology.

[31]  R. Flavell,et al.  IL9 leads to airway inflammation by inducing IL13 expression in airway epithelial cells. , 2006, International immunology.

[32]  Q. Hamid,et al.  Expression of IL-9 receptor alpha chain on human germinal center B cells modulates IgE secretion. , 2007, The Journal of allergy and clinical immunology.

[33]  David C. Gondek,et al.  Mast cells are essential intermediaries in regulatory T-cell tolerance , 2006, Nature.

[34]  GrencisRK LeechMD Induction of enhanced immunity to intestinal nematodes using IL-9-producing dendritic cells. , 2006 .

[35]  J. Renauld,et al.  IL-9 Promotes but Is Not Necessary for Systemic Anaphylaxis1 , 2005, The Journal of Immunology.

[36]  M. Klemsz,et al.  PU.1 expression delineates heterogeneity in primary Th2 cells. , 2005 .

[37]  J. Van Snick,et al.  IL-9 Is a Susceptibility Factor in Leishmania major Infection by Promoting Detrimental Th2/Type 2 Responses1 , 2005, The Journal of Immunology.

[38]  J. Kere,et al.  Sex specific protective effects of interleukin-9 receptor haplotypes on childhood wheezing and sensitisation , 2004, Journal of Medical Genetics.

[39]  P. Zhou,et al.  Mast Cell-Dependent Control of Giardia lamblia Infections in Mice , 2004, Infection and Immunity.

[40]  Q. Hamid,et al.  IL-9-Mediated Induction of Eotaxin1/CCL11 in Human Airway Smooth Muscle Cells1 , 2004, The Journal of Immunology.

[41]  Kenneth G. C. Smith,et al.  Lymphomagenesis, Hydronephrosis, and Autoantibodies Result from Dysregulation of IL-9 and Are Differentially Dependent on Th2 Cytokines1 , 2004, The Journal of Immunology.

[42]  J. Renauld,et al.  IL-9-Induced Expansion of B-1b Cells Restores Numbers but Not Function of B-1 Lymphocytes in xid Mice1 , 2004, The Journal of Immunology.

[43]  S. Tóth,et al.  IL-9 increases the expression of several cytokines in activated mast cells, while the IL-9-induced IL-9 production is inhibited in mast cells of histamine-free transgenic mice. , 2004, Cytokine.

[44]  L. Cosmi,et al.  Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. , 2004, Blood.

[45]  J. Renauld,et al.  IL9 maps to mouse chromosome 13 and human chromosome 5 , 2004, Immunogenetics.

[46]  J. Boyce,et al.  FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines , 2003 .

[47]  M. Aldrich,et al.  Interleukin-9 induces mucous cell metaplasia independent of inflammation. , 2003, American journal of respiratory cell and molecular biology.

[48]  E. Silverman,et al.  Interleukin-9 influences chemokine release in airway smooth muscle: role of ERK. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[49]  K. Koike,et al.  IL-9 Enhances the Growth of Human Mast Cell Progenitors Under Stimulation with Stem Cell Factor1 , 2003, The Journal of Immunology.

[50]  J. Renauld,et al.  MAP kinase activation by interleukin-9 in lymphoid and mast cell lines , 2003, Oncogene.

[51]  T. Moninger,et al.  Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. , 2003, American journal of respiratory cell and molecular biology.

[52]  N. Krug,et al.  Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics. , 2003, Chest.

[53]  J. Boyce,et al.  FcepsilonRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines. , 2003, The Journal of allergy and clinical immunology.

[54]  Y. Sonoda,et al.  Role of human interleukin-9 as a megakaryocyte potentiator in culture. , 2002, Experimental hematology.

[55]  R. Flavell,et al.  Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. , 2002, American journal of respiratory cell and molecular biology.

[56]  T. Mak,et al.  Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Hirata,et al.  Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. , 2002, American journal of respiratory and critical care medicine.

[58]  Philip Smith,et al.  IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. , 2002, Immunity.

[59]  J. Renauld,et al.  IL-9 Inhibits Oxidative Burst and TNF-α Release in Lipopolysaccharide-Stimulated Human Monocytes Through TGF-β1 , 2002, The Journal of Immunology.

[60]  A. McKenzie,et al.  The Absence of Interleukin 9 Does Not Affect the Development of Allergen-induced Pulmonary Inflammation nor Airway Hyperreactivity , 2002, The Journal of experimental medicine.

[61]  J. Renauld,et al.  IL-9 inhibits oxidative burst and TNF-alpha release in lipopolysaccharide-stimulated human monocytes through TGF-beta. , 2002, Journal of immunology.

[62]  R. Flavell,et al.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. , 2002, The Journal of clinical investigation.

[63]  R. Egan,et al.  Effect of anti-mIL-9 antibody on the development of pulmonary inflammation and airway hyperresponsiveness in allergic mice. , 2001, American journal of respiratory cell and molecular biology.

[64]  E. Serfling,et al.  Il-9 and Il-13 Production by Activated Mast , 2013 .

[65]  Q. Hamid,et al.  Functional Expression of IL-9 Receptor by Human Neutrophils from Asthmatic Donors: Role in IL-8 Release1 , 2001, The Journal of Immunology.

[66]  D. J. Matthews,et al.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. , 2000, Immunity.

[67]  L. Hültner,et al.  Murine Bone Marrow-Derived Mast Cells as Potent Producers of IL-9: Costimulatory Function of IL-10 and kit Ligand in the Presence of IL-11 , 2000, The Journal of Immunology.

[68]  R. Mailhammer,et al.  In Activated Mast Cells, IL-1 Up-Regulates the Production of Several Th2-Related Cytokines Including IL-9 , 2000, The Journal of Immunology.

[69]  J. Jen,et al.  Interleukin-9 upregulates mucus expression in the airways. , 2000, American journal of respiratory cell and molecular biology.

[70]  J. Renauld,et al.  IL-9 Protects Mice from Gram-Negative Bacterial Shock: Suppression of TNF-α, IL-12, and IFN-γ, and Induction of IL-10 , 2000, The Journal of Immunology.

[71]  J. Renauld,et al.  Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J. Lafitte,et al.  IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. , 2000, The Journal of allergy and clinical immunology.

[73]  S. Erzurum,et al.  Interleukin-9 Receptor Expression in Asthmatic Airways In Vivo , 2000, Lung.

[74]  S. Wenzel,et al.  Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. , 1999, The Journal of clinical investigation.

[75]  J. Renauld,et al.  Interleukin 9–induced In Vivo Expansion of the B-1 Lymphocyte Population , 1999, The Journal of experimental medicine.

[76]  R. Flavell,et al.  Expression of Interleukin 9 in the Lungs of  Transgenic Mice Causes Airway Inflammation, Mast Cell Hyperplasia, and Bronchial Hyperresponsiveness , 1998, The Journal of experimental medicine.

[77]  J. Renauld,et al.  Interleukin-9 Enhances Resistance to the Intestinal Nematode Trichuris muris , 1998, Infection and Immunity.

[78]  M. Goldsmith,et al.  Heteromerization of the γc Chain with the Interleukin-9 Receptor α Subunit Leads to STAT Activation and Prevention of Apoptosis* , 1998, The Journal of Biological Chemistry.

[79]  M. Goldsmith,et al.  Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. , 1998, Journal of Biological Chemistry.

[80]  J. Renauld,et al.  Interleukin‐9 is involved in host protective immunity to intestinal nematode infection , 1997, European journal of immunology.

[81]  M. Tsang,et al.  Critical Cytoplasmic Domains of Human Interleukin-9 Receptor α Chain in Interleukin-9-mediated Cell Proliferation and Signal Transduction* , 1997, The Journal of Biological Chemistry.

[82]  J. Renauld,et al.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9 , 1996, Molecular and cellular biology.

[83]  W. Luo,et al.  Multiple Transcription Factors Are Required for Activation of Human Interleukin 9 Gene in T Cells* , 1996, The Journal of Biological Chemistry.

[84]  G. Lienhard,et al.  Interleukin-9 Induces Tyrosine Phosphorylation of Insulin Receptor Substrate-1 via JAK Tyrosine Kinases (*) , 1995, The Journal of Biological Chemistry.

[85]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[86]  R. Kühn,et al.  IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. , 1994, Journal of immunology.

[87]  S. Tura,et al.  Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells. , 1994, Experimental hematology.

[88]  M. Röllinghoff,et al.  Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. , 1993, Immunobiology.

[89]  K. Austen,et al.  Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. , 1993, Journal of immunology.

[90]  J. Bousquet,et al.  Interleukin‐9 potentiates the interleukin‐4‐induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes , 1993, European journal of immunology.

[91]  P. Braquet,et al.  Interleukin-9 potentiates the interleukin-4-induced IgE and IgG1 release from murine B lymphocytes. , 1993, Immunology.

[92]  J. Renauld,et al.  Expression cloning of the murine and human interleukin 9 receptor cDNAs. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[93]  J. Renauld,et al.  IL-2 dependence of IL-9 expression in human T lymphocytes. , 1992, Journal of immunology.

[94]  J. Snick,et al.  IL-1 serves as a secondary signal for IL-9 expression. , 1991, Journal of immunology.

[95]  K. Schibler,et al.  Effect of interleukin-9 on clonogenic maturation and cell-cycle status of fetal and adult hematopoietic progenitors. , 1991, Blood.

[96]  C. Uyttenhove,et al.  Functional and biochemical characterization of mouse P40/IL-9 receptors. , 1990, Journal of immunology.

[97]  C. Uyttenhove,et al.  Mast cell growth‐enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9) , 1990, European journal of immunology.

[98]  D. Williams,et al.  T-cell growth factor P40 promotes the proliferation of myeloid cell lines and enhances erythroid burst formation by normal murine bone marrow cells in vitro. , 1990, Blood.

[99]  R. Donahue,et al.  Human P40 T-cell growth factor (interleukin-9) supports erythroid colony formation. , 1990, Blood.

[100]  J. Snick,et al.  Tcgfiii/p40 is produced by naive murine cd4+ t cells but is not a general t cell growth factor* , 1989 .

[101]  R. Moritz,et al.  Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40) , 1989, The Journal of experimental medicine.

[102]  J. Van Snick,et al.  TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. , 1989, European journal of immunology.

[103]  S. Clark,et al.  Expression cloning of cDNA encoding a novel human hematopoietic growth factor: human homologue of murine T-cell growth factor P40. , 1989, Blood.

[104]  C. Uyttenhove,et al.  Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.